Tuesday, 06. January 2009

Life sciences


Advanced genomics and its applications for health



Combating major diseases



Applications-orientated genomic approaches to medical knowledge and technologies



Combating cardiovascular diseases, diabetes, and rare diseases



Combating resistance to antibiotics and other drugs



Studying the brain and combating diseases of the nervous system



Studying human development and the ageing process



Combating cancer



Confronting the major communicable diseases linked to poverty



Specific support actions across thematic priority 1


Policy support

International co-operation

Reporting module


CORANIX - COMBATING RESISTANCE TO ANTIBIOTICS (Life sciences, genomics and biotechnology for health) (2006-01-01 - 2008-12-31) (»add to infobox)



ACRONYM:CORANIX
BUDGET:2.151.600 €
FUNDING:1.795.500 €
INSTRUMENT:Specific Targeted Research Project
PROGRAMME:Life sciences, genomics and biotechnology for health
Combating bacteria with antibiotics is an endless race because bacteria acquire antibiotic resistance (AR) genes easily from unknown environmental sources. Until now, understanding and control of AR spread was attempted through the precise descriptions of AR genes presently found in hospitals, and inference from this of the working mechanisms of dispersion (epidemiological approach). We think that an appropriate long-term public health objective would be to elucidate the molecular mechanisms behind the observed AR spread in a concerted strategy targeting the dissemination modules, from AR recruitment to their ultimate acquisition by bacterial pathogens. Thus, the focus of this project is to explore a mechanistic approach to combat AR. A coherent picture, which could explain the road to multiple AR in gram-negative species, is beginning to emerge from research on gene mobility. Starting from the superintegrons, which could be considered as the "cradles" of many AR, integron cassettes are recruited into integron platforms carried by transposons or plasmids. Insertion sequences (IS) capture genes or integron platforms to form transposons, which are subsequently translocated to conjugative plasmids. Plasmids transfer AR and establish themselves with variable efficiency in pathogenic bacteria. Finally, plasmids need to be stably inherited once they established themselves in a recipient cell. Specific mechanisms ensure that plasmid-free cells are eliminated. The objectives of CORANIX deal with each of the dissemination modules in this chain ¿ integrons (WP1), transposons (WP2), conjugative plasmids (WP3) and stability modules (WP4) ¿ in a concerted approach. We concentrate on the as yet improperly studied aspects of these mechanisms. WP1: mechanism of integron cassette recombination, signals triggering integrase expression and molecular evolution of gene cassettes. WP2: Propensities of three major classes of IS to acquire, stabilise and vehicle AR genes and identification

COORDINATOR (1/1) 


Didier MAZEL (Contact / INSTITUT PASTEUR (FR101 - Paris) (FR - France))

PARTICIPANTS (7/7) 


Michael CHANDLER (Contact / CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR101 - Paris) (FR - France))

Fernando DE LA CRUZ (Contact / UNIVERSIDAD DE CANTABRIA (ES130 - Cantabria) (ES - Spain))

Ferenc OLASZ (Contact / MEZOGAZDASAGI BIOTECHNOLOGIAI KUTATOKOZPONT (HU102 - Pest) (HU - Hungary))

Ellen L. ZECHNER (Contact / KARL-FRANZENS-UNIVERSITAET GRAZ (AT221 - Graz) (AT - Austria))

Laurence VAN MELDEREN (Contact / UNIVERSITE LIBRE DE BRUXELLES (BE100 - Arr. de Bruxelles-Capitale) (BE - Belgium))

Finbarr HAYES (Contact / THE UNIVERSITY OF MANCHESTER (UKD31 - Greater Manchester South) (UK - Great Britain))

Philippe GABANT (Contact / DELPHI GENETICS SA (BE322 - Arr. Charleroi) (BE - Belgium))

RELATED THEMATIC AREAS (1/1) 

Combating resistance to antibiotics and other drugs




SEARCH



»Advanced Search



SHORT CUTS

»Thematic areas

»Organisations

»Persons



INFOBOX (0/0) show all
Your infobox is empty


LifeCompetence is operated by AVEDAS.
LifeCompetence operated by AVEDAS
Contact: support@avedas.com


Powered by CONVERIS 2.0